The electrochemical and magnetic biosensors have an advantage because of the easy miniaturization of electric device components as compared with photometric instruments. These technologies have been applied to develop portable, compact and inexpensive biochip devices. A commercially successful example is the glucose sensor using enzyme transducers, which was originally reported by Clark and Lyons [1] to measure glucose by detecting the decrease in oxygen by pO 2 electrode when glucose is converted to gluconic acid and hydrogen peroxide. Electrochemical biosensors can be separated into three typical assay systems using amperometric, potentiometric or conductometric transducers. Furthermore, various magnetosensors using magnetic particles have been developed over a decade in place of photometric biosensors. In this chapter, recent advances in electrochemical and magnetic biosensors toward development of portable, compact and inexpensive biochip devices have been focused.Electrochemical biosensors have been divided into two basic types: enzyme-based sensor and electrochemical probe-based sensor. Alkaline phosphatase (ALP) and horse radish peroxidase (HRP) have been often employed for enzyme-based biosensors using p-nitrophenyl phosphate (PNP), a-naphtyl phosphate, 3-3¢,5,5¢-tetramethylbenzidine (TMB) and 2,2¢-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) as substrates of electrochemically active species, and ferrocene (Fc) and methylene blue as the electrochemical mediators. In general, enzymatic amplification of electrochemical signals enables highly sensitive detection of analytes. On the other hand, a direct detection of analytes by using electrochemical probes allows a more rapid time-response onto the detector surface and needs no enzymatic reaction. Based on the reason, a direct detection of analytes by using electrochemical probes has been